Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Malaria Journal
Published in: Malaria Journal 1/2017

Open Access 01-12-2017 | Review

Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination

Authors: Judith Recht, André M. Siqueira, Wuelton M. Monteiro, Sonia M. Herrera, Sócrates Herrera, Marcus V. G. Lacerda

Published in: Malaria Journal | Issue 1/2017

Login to get access

Abstract

In spite of significant progress towards malaria control and elimination achieved in South America in the 2000s, this mosquito-transmitted tropical disease remains an important public health concern in the region. Most malaria cases in South America come from Amazon rain forest areas in northern countries, where more than half of malaria is caused by Plasmodium vivax, while Plasmodium falciparum malaria incidence has decreased in recent years. This review discusses current malaria data, policies and challenges in four South American Amazon countries: Brazil, Colombia, Peru and the Bolivarian Republic of Venezuela. Challenges to continuing efforts to further decrease malaria incidence in this region include: a significant increase in malaria cases in recent years in Venezuela, evidence of submicroscopic and asymptomatic infections, peri-urban malaria, gold mining-related malaria, malaria in pregnancy, glucose-6-phosphate dehydrogenase (G6PD) deficiency and primaquine use, and possible under-detection of Plasmodium malariae. Some of these challenges underscore the need to implement appropriate tools and procedures in specific regions, such as a field-compatible molecular malaria test, a P. malariae-specific test, malaria diagnosis and appropriate treatment as part of regular antenatal care visits, G6PD test before primaquine administration for P. vivax cases (with weekly primaquine regimen for G6PD deficient individuals), single low dose of primaquine for P. falciparum malaria in Colombia, and national and regional efforts to contain malaria spread in Venezuela urgently needed especially in mining areas. Joint efforts and commitment towards malaria control and elimination should be strategized based on examples of successful regional malaria fighting initiatives, such as PAMAFRO and RAVREDA/AMI.
Literature
1.
WHO. World Malaria Report. Geneva: World Health Organization; 2016.
2.
PAHO. Plan of action for malaria elimination 2016–2020 (CD55/13). 55th directing council, 68th session of the PAHO regional committte. Washington, D.C.: Pan American Health Organization/World Health Organization; 2016.
3.
Pina-Costa Ad, Brasil P, Santi SMD, Araujo MPd, Suárez-Mutis MC, Santelli ACFeS, et al. Malaria in Brazil: what happens outside the Amazonian endemic region. Mem Inst Oswaldo Cruz. 2014;109:618–33.PubMedPubMedCentralCrossRef
4.
Rodríguez JCP, Uribe GÁ, Araújo RM, Narváez PC, Valencia SH. Epidemiology and control of malaria in Colombia. Mem Inst Oswaldo Cruz. 2011;106:114–22.PubMedPubMedCentralCrossRef
5.
Annual Report FY 2015. Amazon malaria initiative; 2016.
6.
Carter KH, Singh P, Mujica OJ, Escalada RP, Ade MP, Castellanos LG, et al. Malaria in the Americas: trends from 1959 to 2011. Am J Trop Med Hyg. 2015;92:302–16.PubMedPubMedCentralCrossRef
7.
PAHO. Alerta Epidemiológica: Aumento de casos de malaria; 2017.
8.
INS. Boletín epidemiologico semanal No. 52 Colombia.
9.
Ministerio del Poder Popular para la Salud, Gobierno Bolivariano de Venezuela. Boletín Epidemilógico Semana Epidemiologica No. 52; 2016.
10.
11.
12.
Siqueira AM, Mesones-Lapouble O, Marchesini P, de Souza Sampaio V, Brasil P, Tauil PL, et al. Plasmodium vivax landscape in Brazil: scenario and challenges. Am J Trop Med Hyg. 2016;95(Suppl 6):87–96.PubMedPubMedCentralCrossRef
13.
14.
Olliaro PL, Barnwell JW, Barry A, Mendis K, Mueller I, Reeder JC, et al. Implications of Plasmodium vivax biology for control, elimination, and research. Am J Trop Med Hyg. 2016;95(Suppl 6):4–14.PubMedPubMedCentralCrossRef
15.
Howes RE, Battle KE, Mendis KN, Smith DL, Cibulskis RE, Baird JK, et al. Global epidemiology of Plasmodium vivax. Am J Trop Med Hyg. 2016;95(Suppl 6):15–34.PubMedPubMedCentralCrossRef
16.
Lacerda MVGd, Zackiewicz C, Alecrim WD, Alecrim MdGC. The neglected Plasmodium vivax: are researchers from endemic areas really concerned about new treatment options? Rev Soc Bras Med Trop. 2007;40:489–90.PubMedCrossRef
17.
Rodriguez-Morales AJ, Bolívar-Mejía A, Alarcón-Olave C, Calvo-Betancourt LS. Plasmodium vivax malaria in Latin America. In: Franco-Paredes C, Santos-Preciado JI, editors. Neglected tropical diseases—latin America and the Caribbean. Vienna: Springer Vienna; 2015. p. 89–111.CrossRef
18.
Quispe AM, Pozo E, Guerrero E, Durand S, Baldeviano GC, Edgel KA, et al. Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg. 2014;91:11–7.PubMedPubMedCentralCrossRef
19.
Alexandre MA, Ferreira CO, Siqueira AM, Magalhaes BL, Mourao MP, Lacerda MV, et al. Severe Plasmodium vivax malaria, Brazilian Amazon. Emerg Infect Dis. 2010;16:1611–4.PubMedPubMedCentralCrossRef
20.
Andrade BB, Reis-Filho A, Souza-Neto SM, Clarêncio J, Camargo LMA, Barral A, et al. Severe Plasmodium vivax malaria exhibits marked inflammatory imbalance. Malar J. 2010;9:13.PubMedPubMedCentralCrossRef
21.
Siqueira AM, Lacerda MVG, Magalhães BML, Mourão MPG, Melo GC, Alexandre MAA, et al. Characterization of Plasmodium vivax-associated admissions to reference hospitals in Brazil and India. BMC Med. 2015;13:57.PubMedPubMedCentralCrossRef
22.
Lacerda MV, Fragoso SC, Alecrim MG, Alexandre MA, Magalhaes BM, Siqueira AM, et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis. 2012;55:e67–74.PubMedCrossRef
23.
Chaparro-Narváez PE, Lopez-Perez M, Rengifo LM, Padilla J, Herrera S, Arévalo-Herrera M. Clinical and epidemiological aspects of complicated malaria in Colombia, 2007–2013. Malar J. 2016;15:269.PubMedPubMedCentralCrossRef
24.
Medina-Morales DA, Montoya-Franco E, Sanchez-Aristizabal VD, Machado-Alba JE, Rodriguez-Morales AJ. Severe and benign Plasmodium vivax malaria in Embera (Amerindian) children and adolescents from an endemic municipality in Western Colombia. J Infect Public Health. 2016;9:172–80.PubMedCrossRef
25.
Arevalo-Herrera M, Lopez-Perez M, Medina L, Moreno A, Gutierrez JB, Herrera S. Clinical profile of Plasmodium falciparum and Plasmodium vivax infections in low and unstable malaria transmission settings of Colombia. Malar J. 2015;14:154.PubMedPubMedCentralCrossRef
26.
27.
Vinetz JM, Li J, McCutchan TF, Kaslow DC. Plasmodium malariae infection in an asymptomatic 74-year-old Greek woman with splenomegaly. N Engl J Med. 1998;338:367–71.PubMedCrossRef
28.
Chadee DD, Tilluckdharry CC, Maharaj P, Sinanan C. Reactivation of Plasmodium malariae infection in a Trinidadian man after neurosurgery. N Engl J Med. 2000;342:1924.PubMedCrossRef
29.
Siala E, Khalfaoui M, Bouratbine A, Hamdi S, Hili K, Aoun K. Relapse of Plasmodium malariae malaria 20 years after living in an endemic area (in French). Presse Med. 2005;34:371–2.PubMedCrossRef
30.
Tsuchida H, Yamaguchi K, Yamamoto S, Ebisawa I. Quartan malaria following splenectomy 36 years after infection. Am J Trop Med Hyg. 1982;31:163–5.PubMedCrossRef
31.
Alho RM, Machado KVA, Val FFA, Fraiji NA, Alexandre MAA, Melo GC, et al. Alternative transmission routes in the malaria elimination era: an overview of transfusion-transmitted malaria in the Americas. Malar J. 2017;16:78.PubMedPubMedCentralCrossRef
32.
Sulzer AJ, Cantella R, Colichon A, Gleason NN, Walls KW. A focus of hyperendemic Plasmodium malariae–P. vivax with no P. falciparum in a primitive population in the Peruvian Amazon jungle. Bull World Health Organ. 1975;52:273–8.PubMedPubMedCentral
33.
Scopel KK, Fontes CJ, Nunes AC, Horta MF, Braga EM. High prevalence of Plamodium malariae infections in a Brazilian Amazon endemic area (Apiacas-Mato Grosso State) as detected by polymerase chain reaction. Acta Trop. 2004;90:61–4.PubMedCrossRef
34.
Peek R, Van Gool T, Panchoe D, Greve S, Bus E, Resida L. Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname. Am J Trop Med Hyg. 2005;73:833–8.PubMed
35.
Camargo-Ayala PA, Cubides JR, Niño CH, Camargo M, Rodríguez-Celis CA, Quiñones T, et al. High Plasmodium malariae prevalence in an endemic area of the Colombian Amazon Region. PLoS ONE. 2016;11:e0159968.PubMedPubMedCentralCrossRef
36.
Niño CH, Cubides JR, Camargo-Ayala PA, Rodríguez-Celis CA, Quiñones T, Cortés-Castillo MT, et al. Plasmodium malariae in the Colombian Amazon region: you don’t diagnose what you don’t suspect. Malar J. 2016;15:576.PubMedPubMedCentralCrossRef
37.
Vergara J, Hurtado S, Alvarez VH, Arévalo M, Herrera S. Caracterización de la transmisión de Plasmodium malariae en cuatro regiones colombianas endémicas de malaria. Biomedica. 2001;21:53–61.CrossRef
38.
Lalremruata A, Magris M, Vivas-Martínez S, Koehler M, Esen M, Kempaiah P, et al. Natural infection of Plasmodium brasilianum in humans: man and monkey share quartan malaria parasites in the Venezuelan Amazon. EBioMedicine. 2015;2:1186–92.PubMedPubMedCentralCrossRef
39.
Coatney GR, Collins WE, Warren M, Contacos PG. Plasmodium brasilianum. The primate malarias. Atlanta: CDC; 2003. p. 231–44 [electronic version (original book published 1971)].
40.
Fandeur T, Volney B, Peneau C, de Thoisy B. Monkeys of the rainforest in French Guiana are natural reservoirs for P. brasilianum/P. malariae malaria. Parasitology. 2000;120:11–21.PubMedCrossRef
41.
Tazi L, Ayala FJ. Unresolved direction of host transfer of Plasmodium vivax v. P. simium and P. malariae v. P. brasilianum. Infect Genet Evol. 2011;11:209–21.PubMedCrossRef
42.
de Alvarenga DA, de Pina-Costa A, de Sousa TN, Pissinatti A, Zalis MG, Suarez-Mutis MC, et al. Simian malaria in the Brazilian Atlantic forest: first description of natural infection of capuchin monkeys (Cebinae subfamily) by Plasmodium simium. Malar J. 2015;14:81.PubMedPubMedCentralCrossRef
43.
Woodall J. Case report: malaria attack in southern Brazil—five-decade relapse, simian malaria or something else? Infect Ecol Epidemiol. 2016;6:30139.PubMedCrossRef
44.
Braz RM, Tauil PL, Santelli ACFeS, Fontes CJF. Avaliação da completude e da oportunidade das notificações de malária na Amazônia Brasileira, 2003–2012. Epidemiologia e Serviços de Saúde. 2016;25:21–32.PubMedCrossRef
45.
Guía para la atención clínica integral del paciente con malaria. Bogotá: INS (Instituto Nacional de Salud); 2010.
46.
Guía prático de tratamento da malária no Brasil. Brasilia: Ministério da Saúde; 2010.
47.
WHO. World Malaria Report 2015. Geneva: World Health Organization; 2015.
48.
Grietens KP, Soto V, Erhart A, Ribera JM, Toomer E, Tenorio A, et al. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Am J Trop Med Hyg. 2010;82:1017–23.PubMedPubMedCentralCrossRef
49.
50.
51.
Ladeia-Andrade S, de Melo GN, de Souza-Lima Rde C, Salla LC, Bastos MS, Rodrigues PT, et al. No clinical or molecular evidence of Plasmodium falciparum resistance to artesunate-mefloquine in Northwestern Brazil. Am J Trop Med Hyg. 2016;95:148–54.PubMedCrossRef
52.
Changes to malaria treatment guidelines, Peru MoH [in Spanish]. Peru; 2015.
53.
WHO. Single dose primaquine as a gametocytocide in Plasmodium falciparum malaria; updated WHO policy recommendation. Geneva: World Health Organization; 2012.
54.
Cáceres GJL. Récord de incidencia malárica en Venezuela. Boletín de Malariología y Salud Ambiental. 2013;53:88–98.
55.
Casey N. Hard times in Venezuela breed malaria as desperate flock to mines. New York: The New York Times; 2016.
56.
OVS. Epidemia de malaria, sin control ni medicamentos, podría llegar a 350 mil casos al finalizar 2016. Venezuela: Observatorio Venezolano de la Salud; 2016.
57.
Krisher LK, Krisher J, Ambuludi M, Arichabala A, Beltrán-Ayala E, Navarrete P, et al. Successful malaria elimination in the Ecuador–Peru border region: epidemiology and lessons learned. Malar J. 2016;15:573.PubMedPubMedCentralCrossRef
58.
PAHO. Transcending politics and using evidence-based treatment policies and public health approaches in combating malaria: the Amazon malaria initiative (AMI) and the Amazon Network for the Surveillance of Antimalarial Drug Resistance (RAVREDA) Partnership. 2007.
59.
Rosas-Aguirre A, Gamboa D, Manrique P, Conn JE, Moreno M, Lescano AG, et al. Epidemiology of Plasmodium vivax malaria in Peru. Am J Trop Med Hyg. 2016;95(Suppl 6):133–44.PubMedPubMedCentralCrossRef
60.
Wilson ML, Krogstad DJ, Arinaitwe E, Arevalo-Herrera M, Chery L, Ferreira MU, et al. Urban malaria: understanding its epidemiology, ecology, and transmission across seven diverse ICEMR Network Sites. Am J Trop Med Hyg. 2015;93(Suppl 3):110–23.PubMedPubMedCentralCrossRef
61.
Sampaio VS, Siqueira AM, Alecrim M, Mourao MP, Marchesini PB, Albuquerque BC, et al. Malaria in the State of Amazonas: a typical Brazilian tropical disease influenced by waves of economic development. Rev Soc Bras Med Trop. 2015;48(Suppl 1):4–11.PubMedCrossRef
62.
Tada MS, Marques RP, Mesquita E, Dalla Martha RC, Rodrigues JA, Costa JD, et al. Urban malaria in the Brazilian Western Amazon Region I: high prevalence of asymptomatic carriers in an urban riverside district is associated with a high level of clinical malaria. Mem Inst Oswaldo Cruz. 2007;102:263–9.PubMedCrossRef
63.
Gil LH, Tada MS, Katsuragawa TH, Ribolla PE, da Silva LH. Urban and suburban malaria in Rondonia (Brazilian Western Amazon) II. Perennial transmissions with high anopheline densities are associated with human environmental changes. Mem Inst Oswaldo Cruz. 2007;102:271–6.PubMedCrossRef
64.
Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, et al. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J. 2005;4:27.PubMedPubMedCentralCrossRef
65.
Rosas-Aguirre A, Llanos-Cuentas A, Speybroeck N, Cook J, Contreras-Mancilla J, Soto V, et al. Assessing malaria transmission in a low endemicity area of north-western Peru. Malar J. 2013;12:339.PubMedPubMedCentralCrossRef
66.
Arróspide N, Miranda E, Casas JV. Malaria urbana por Plasmodium vivax en La Molina, Lima. Revista Peruana de Medicina Experimental y Salud Publica. 2007;24:192–3.
67.
68.
Castellanos A, Chaparro-Narvaez P, Morales-Plaza CD, Alzate A, Padilla J, Arevalo M, et al. Malaria in gold-mining areas in Colombia. Mem Inst Oswaldo Cruz. 2016;111:59–66.PubMedPubMedCentralCrossRef
69.
de Andrade AL, Martelli CM, Oliveira RM, Arias JR, Zicker F, Pang L. High prevalence of asymptomatic malaria in gold mining areas in Brazil. Clin Infect Dis. 1995;20:475.PubMedCrossRef
70.
da Silva-Nunes M, Moreno M, Conn JE, Gamboa D, Abeles S, Vinetz JM, et al. Amazonian malaria: asymptomatic human reservoirs, diagnostic challenges, environmentally driven changes in mosquito vector populations, and the mandate for sustainable control strategies. Acta Trop. 2012;121:281–91.PubMedCrossRef
71.
Ferreira IM, Yokoo EM, Souza-Santos R, Galvao ND, Atanaka-Santos M. Factors associated with the incidence of malaria in settlement areas in the district of Juruena, Mato Grosso state, Brazil. Cien Saude Colet. 2012;17:2415–24.PubMedCrossRef
72.
Parker BS, Paredes Olortegui M, Peñataro Yori P, Escobedo K, Florin D, Rengifo Pinedo S, et al. Hyperendemic malaria transmission in areas of occupation-related travel in the Peruvian Amazon. Malar J. 2013;12:178.PubMedPubMedCentralCrossRef
73.
Douine M, Musset L, Corlin F, Pelleau S, Pasquier J, Mutricy L, et al. Prevalence of Plasmodium spp. in illegal gold miners in French Guiana in 2015: a hidden but critical malaria reservoir. Malar J. 2015;2016(15):315.
74.
Moreno JE, Rubio-Palis Y, Martínez ÁR, Acevedo P. Evolución espacial y temporal de la malaria en el municipio Sifontes del estado Bolívar, Venezuela, 1980–2013. Boletín de Malariología y Salud Ambiental. 2014;54:236–49.
75.
Breeveld FJ, Vreden SG, Grobusch MP. History of malaria research and its contribution to the malaria control success in Suriname: a review. Malar J. 2012;11:95.PubMedPubMedCentralCrossRef
76.
Atanaka-Santos M, Czeresnia D, Souza-Santos R, Oliveira RM. Comportamento epidemiológico da malária no Estado de Mato Grosso, 1980–2003. Rev Soc Bras Med Trop. 2006;39:187–92.PubMedCrossRef
77.
Santos VRd, Yokoo EM, Souza-Santos R, Atanaka-Santos M. Fatores socioambientais associados à distribuição espacial de malária no assentamento Vale do Amanhecer, Município de Juruena, Estado de Mato Grosso, 2005. Rev Soc Bras Med Trop. 2009;42:47–53.PubMedCrossRef
78.
Duarte EC, Fontes CJ. Association between reported annual gold mining extraction and incidence of malaria in Mato Grosso-Brazil, 1985–1996. Rev Soc Bras Med Trop. 2002;35:665–8 (In Portuguese).PubMedCrossRef
79.
80.
Hiwat H, Hardjopawiro LS, Takken W, Villegas L. Novel strategies lead to pre-elimination of malaria in previously high-risk areas in Suriname, South America. Malar J. 2012;11:10.PubMedPubMedCentralCrossRef
81.
82.
Campos IM, Uribe ML, Cuesta C, Franco-Gallego A, Carmona-Fonseca J, Maestre A. Diagnosis of gestational, congenital, and placental malaria in Colombia: comparison of the efficacy of microscopy, nested polymerase chain reaction, and histopathology. Am J Trop Med Hyg. 2011;84:929–35.PubMedPubMedCentralCrossRef
83.
Agudelo O, Arango E, Maestre A, Carmona-Fonseca J. Prevalence of gestational, placental and congenital malaria in north-west Colombia. Malar J. 2013;12:341.PubMedPubMedCentralCrossRef
84.
Gabriel Piñeros J, Tobon-Castaño A, Álvarez G, Portilla C, Blair S. Maternal Clinical findings in malaria in pregnancy in a region of Northwestern Colombia. Am J Trop Med Hyg. 2013;89:520–6.PubMedCentralCrossRef
85.
Lopez-Perez M, Pacheco MA, Buriticá L, Escalante AA, Herrera S, Arévalo-Herrera M. Malaria in pregnancy: a passive surveillance study of pregnant women in low transmission areas of Colombia, Latin America. Malar J. 2016;15:66.PubMedPubMedCentralCrossRef
86.
Almeida LB, Barbosa M, Martinez-Espinosa FE. Malaria among women aged 10 to 49 years, according to SIVEP-Malaria, Manaus, State of Amazonas, 2003–2006. Rev Soc Bras Med Trop. 2010;43:304–8 (In Portuguese).PubMedCrossRef
87.
Luz TC, Suarez-Mutis MC, Miranda ES, Moritz AF, Freitas LF, Brasil Jde C, et al. Uncomplicated malaria among pregnant women in the Brazilian Amazon: local barriers to prompt and effective case management. Acta Trop. 2013;125:137–42.PubMedCrossRef
88.
Hristov AD, Sanchez MCA, Ferreira JJB, Lima GFMdC, Inoue J, Costa-Nascimento MdJ, et al. Malaria in pregnant women living in areas of low transmission on the southeast Brazilian Coast: molecular diagnosis and humoural immunity profile. Mem Inst Oswaldo Cruz. 2014;109:1014–20.PubMedPubMedCentralCrossRef
89.
Parekh FK, Hernandez JN, Krogstad DJ, Casapia WM, Branch OH. Prevalence and risk of Plasmodium falciparum and P. vivax malaria among pregnant women living in the hypoendemic communities of the Peruvian Amazon. Am J Trop Med Hyg. 2007;77:451–7.PubMedPubMedCentral
90.
Parekh FK, Davison BB, Gamboa D, Hernandez J, Branch OH. Placental histopathologic changes associated with subclinical malaria infection and its impact on the fetal environment. Am J Trop Med Hyg. 2010;83:973–80.PubMedPubMedCentralCrossRef
91.
Arróspide N, Espinoza MM, Miranda-Choque E, Mayta-Tristán P, Legua P, Cabezas C. Muerte materna por malaria grave por Plasmodium vivax. Rev Peru Med Exp Salud Publica. 2016;33:368–72.PubMedCrossRef
92.
Gómez E, López E, Ache A. Malaria y embarazo: parroquia San Isidro, municipio Sifontes, estado Bolívar, Venezuela, años 2005–2006. Investigación Clínica. 2009;50:455–64.PubMed
93.
Campbell CC, Chin W, Collins WE, Teutsch SM, Moss DM. Chloroquine-resistant Plasmodium falciparum from East Africa: cultivation and drug sensitivity of the Tanzanian I/CDC strain from an American tourist. Lancet. 1979;2:1151–4.PubMedCrossRef
94.
Young MD, Moore DV. Chloroquine resistance in Plasmodium falciparum. Am J Trop Med Hyg. 1961;10:317–20.PubMedCrossRef
95.
Harinasuta T, Migasena S, Bunnag D. Chloroquine resistance in Plasmodium falciparum in Thailand. Proceedings of the first UNESCO regional symposium; 1961.
96.
Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411–23.PubMedPubMedCentralCrossRef
97.
Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50–5.PubMedCrossRef
98.
Straimer J, Gnadig NF, Witkowski B, Amaratunga C, Duru V, Ramadani AP, et al. Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates. Science. 2015;347:428–31.PubMedCrossRef
99.
Rahman R, Martin MJS, Persaud S, Ceron N, Kellman D, Musset L, et al. Continued sensitivity of Plasmodium falciparum to artemisinin in Guyana, with absence of kelch propeller domain mutant alleles. Open Forum Infect Dis. 2016;3:185.CrossRef
100.
Menard D, Khim N, Beghain J, Adegnika AA, Shafiul-Alam M, Amodu O, et al. A Worldwide map of Plasmodium falciparum K13-propeller polymorphisms. N Engl J Med. 2016;374:2453–64.PubMedPubMedCentralCrossRef
101.
Mukherjee A, Bopp S, Magistrado P, Wong W, Daniels R, Demas A, et al. Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia. Malar J. 2017;16:195.PubMedPubMedCentralCrossRef
102.
de Santana Filho FS, de Lima Arcanjo AR, Chehuan YM, Costa MR, Martinez-Espinosa FE, Vieira JL, et al. Chloroquine-resistant Plasmodium vivax, Brazilian Amazon. Emerg Infect Dis. 2007;13:1125–6.PubMedPubMedCentralCrossRef
103.
Marques MM, Costa MR, Santana Filho FS, Vieira JL, Nascimento MT, Brasil LW, et al. Plasmodium vivax chloroquine resistance and anemia in the western Brazilian Amazon. Antimicrob Agents Chemother. 2014;58:342–7.PubMedPubMedCentralCrossRef
104.
Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, et al. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS ONE. 2010;5:e8091.PubMedPubMedCentralCrossRef
105.
Akinyi S, Hayden T, Gamboa D, Torres K, Bendezu J, Abdallah JF, et al. Multiple genetic origins of histidine-rich protein 2 gene deletion in Plasmodium falciparum parasites from Peru. Sci Rep. 2013;3:2797.PubMedPubMedCentralCrossRef
106.
Maltha J, Gamboa D, Bendezu J, Sanchez L, Cnops L, Gillet P, et al. Rapid diagnostic tests for malaria diagnosis in the Peruvian Amazon: impact of pfhrp2 gene deletions and cross-reactions. PLoS ONE. 2012;7:e43094.PubMedPubMedCentralCrossRef
107.
WHO. False-negative RDT results and implications of new reports of P. falciparum histidine-rich protein 2/3 gene deletions. Geneva: World Health Organization; 2016.
108.
Imwong M, Hanchana S, Malleret B, Renia L, Day NP, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52:3303–9.PubMedPubMedCentralCrossRef
109.
Imwong M, Nguyen TN, Tripura R, Peto TJ, Lee SJ, Lwin KM, et al. The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand–Myanmar border areas, Cambodia, and Vietnam. Malar J. 2015;14:381.PubMedPubMedCentralCrossRef
110.
111.
Vallejo AF, Chaparro PE, Benavides Y, Alvarez A, Quintero JP, Padilla J, et al. High prevalence of sub-microscopic infections in Colombia. Malar J. 2015;14:201.PubMedPubMedCentralCrossRef
112.
Cucunuba ZM, Guerra AP, Rahirant SJ, Rivera JA, Cortes LJ, Nicholls RS. Asymptomatic Plasmodium spp. infection in Tierralta, Colombia. Mem Inst Oswaldo Cruz. 2008;103:668–73.PubMedCrossRef
113.
Cucunuba ZM, Guerra A, Rivera JA, Nicholls RS. Comparison of asymptomatic Plasmodium spp. infection in two malaria-endemic Colombian locations. Trans R Soc Trop Med Hyg. 2013;107:129–36.PubMedCrossRef
114.
Matisz CE, Naidu P, Shokoples SE, Grice D, Krinke V, Brown SZ, et al. Post-arrival screening for malaria in asymptomatic refugees using real-time PCR. Am J Trop Med Hyg. 2011;84:161–5.PubMedPubMedCentralCrossRef
115.
Ndao M, Bandyayera E, Kokoskin E, Gyorkos TW, MacLean JD, Ward BJ. Comparison of blood smear, antigen detection, and nested-PCR methods for screening refugees from regions where malaria is endemic after a malaria outbreak in Quebec, Canada. J Clin Microbiol. 2004;42:2694–700.PubMedPubMedCentralCrossRef
116.
Vallejo AF, Garcia J, Amado-Garavito AB, Arevalo-Herrera M, Herrera S. Plasmodium vivax gametocyte infectivity in sub-microscopic infections. Malar J. 2016;15:48.PubMedPubMedCentralCrossRef
117.
Martins-Campos KM, Kuehn A, Lima JBP, Pimenta PFP, Rios-Velasquez C, Fe NF, et al. Experimental infection of Anopheles aquasalis by symptomatic and asymptomatic carriers of Plasmodium vivax in the Brazilian Amazon region. American Society of Tropical Medicine and Hygiene 63rd Annual Meeting. New Orleans; 2014.
118.
Coura JR, Suárez-Mutis M, Ladeia-Andrade S. A new challenge for malaria control in Brazil: asymptomatic Plasmodium infection—a review. Mem Inst Oswaldo Cruz. 2006;101:229–37.PubMedCrossRef
119.
Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28:E63.PubMedPubMedCentralCrossRef
120.
Vallejo AF, Martinez NL, Gonzalez IJ, Arevalo-Herrera M, Herrera S. Evaluation of the loop mediated isothermal DNA amplification (LAMP) kit for malaria diagnosis in P. vivax endemic settings of Colombia. PLoS Negl Trop Dis. 2015;9:e3453.PubMedPubMedCentralCrossRef
121.
Kuehn A, Almeida ACG, Castro A, Tadei WP, Figueiredo EFG, Martins-Campos KM, et al. Plasmodium vivax and Plasmodium falciparum gametocyte prevalence in an endemic area in the Brazilian Amazon. New Orleans: American Society of Tropical Medicine and Hygiene 63rd Annual Meeting; 2014.
122.
Sinka ME, Rubio-Palis Y, Manguin S, Patil AP, Temperley WH, Gething PW, et al. The dominant Anopheles vectors of human malaria in the Americas: occurrence data, distribution maps and bionomic précis. Parasit Vectors. 2010;3:72.PubMedPubMedCentralCrossRef
123.
Martins-Campos KM, Pinheiro WD, Vítor-Silva S, Siqueira AM, Melo GC, Rodrigues ÍC, et al. Integrated vector management targeting Anopheles darlingi populations decreases malaria incidence in an unstable transmission area, in the rural Brazilian Amazon. Malar J. 2012;11:351.PubMedPubMedCentralCrossRef
124.
Ahumada ML, Orjuela LI, Pareja PX, Conde M, Cabarcas DM, Cubillos EFG, et al. Spatial distributions of Anopheles species in relation to malaria incidence at 70 localities in the highly endemic Northwest and South Pacific coast regions of Colombia. Malar J. 2016;15:407.PubMedPubMedCentralCrossRef
125.
Conde M, Pareja PX, Orjuela LI, Ahumada ML, Durán S, Jara JA, et al. Larval habitat characteristics of the main malaria vectors in the most endemic regions of Colombia: potential implications for larval control. Malar J. 2015;14:476.PubMedPubMedCentralCrossRef
126.
Beutler E, Duparc S. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. Am J Trop Med Hyg. 2007;77:779–89.PubMed
127.
128.
Luzzatto L, Poggi V. Glucose-6-phosphate dehydrogenase deficiency (chapter 17). In: Orkin, editor. Nathan and Oski’s hematology of infancy and childhood. 7th ed. Alberta: Saunders; 2009.
129.
130.
Beutler E, Vulliamy TJ. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis. 2002;28:93–103.PubMedCrossRef
131.
Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations. Blood Cells Mol Dis. 2012;48:154–65.PubMedCrossRef
132.
Howes RE, Piel FB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9:e1001339.PubMedPubMedCentralCrossRef
133.
Monteiro WM, Val FF, Siqueira AM, Franca GP, Sampaio VS, Melo GC, et al. G6PD deficiency in Latin America: systematic review on prevalence and variants. Mem Inst Oswaldo Cruz. 2014;109:553–68.PubMedPubMedCentralCrossRef
134.
Vizzi E, Bastidas G, Hidalgo M, Colman L, Perez HA. Prevalence and molecular characterization of G6PD deficiency in two Plasmodium vivax endemic areas in Venezuela: predominance of the African A-(202A/376G) variant. Malar J. 2016;15:19.PubMedPubMedCentralCrossRef
135.
Valencia SH, Ocampo ID, Arce-Plata MI, Recht J, Arévalo-Herrera M. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia. Malar J. 2016;15:291.PubMedPubMedCentralCrossRef
136.
Brito MAM, Peixoto HM, Almeida ACGd, Oliveira MRFd, Romero GAS, Moura-Neto JP, et al. Validation of the rapid test Carestart(tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon. Rev Soc Bras Med Trop. 2016;49:446–55.PubMedCrossRef
137.
Compri MB, Saad ST, Ramalho AS. Genetico-epidemiological and molecular investigation of G-6-PD deficiency in a Brazilian community. Cad Saude Publica. 2000;16:335–42 (In Spanish).PubMedCrossRef
138.
Moyano M, Mendez F. Erythrocyte defects and parasitemia density in patients with Plasmodium falciparum malaria in Buenaventura, Colombia. Rev Panam Salud Publica. 2005;18:25–32 (In Spanish).PubMedCrossRef
139.
Carmona-Fonseca J, Álvarez G, Ríos A, Vásquez MF. Deficiencia de glucosa 6-fostato deshidrogenasa en hombres sanos y en pacientes maláricos; Turbo (Antioquia, Colombia). Rev Bras Epidemiol. 2008;11:252–65.CrossRef
140.
Sánchez MC, Villegas VE, Fonseca D. Glucose-6-phosphate dehydrogenase deficiency: enzimatic and molecular analysis in a Bogotá population. Colombia Médica. 2008;39:14–23 (In Spanish).
141.
Alberto Restrepo M, Gutierrez E. The frequency of glucose-6-phosphate dehydrogenase deficiency in Colombia. Am J Hum Genet. 1968;20:82–5.PubMedPubMedCentral
142.
Weimer TA, Salzano FM, Westwood B, Beutler E. Molecular characterization of glucose-6-phosphate dehydrogenase variants from Brazil. Hum Biol. 1993;65:41–7.PubMed
143.
Peixoto HM, Brito MAM, Romero GAS, Monteiro WM, de Lacerda MVG, de Oliveira MRF. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon. Malar J. 2016;15:82.PubMedPubMedCentralCrossRef
144.
Ramos Junior WM, Sardinha JF, Costa MR, Santana MS, Alecrim MG, Lacerda MV. Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon. Braz J Infect Dis. 2010;14:410–2.PubMedCrossRef
145.
Targeting vivax malaria in the Asia Pacific. The Asia Pacific Malaria Elimination Network Vivax Working Group. Malar J. 2015;14:484.CrossRef
146.
WHO. World Malaria Report. Geneva: World Health Organization; 2014.
Metadata
Title
Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination
Authors
Judith Recht
André M. Siqueira
Wuelton M. Monteiro
Sonia M. Herrera
Sócrates Herrera
Marcus V. G. Lacerda
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2017
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/s12936-017-1925-6

Other articles of this Issue 1/2017

Malaria Journal 1/2017 Go to the issue

Research

Evaluation of piperonyl butoxide in enhancing the efficacy of pyrethroid insecticides against resistant Anopheles gambiae s.l. in Ghana

Research

Progress in coverage of bed net ownership and use in Burkina Faso 2003–2014: evidence from population-based surveys

Review

The role of extracellular vesicles in malaria biology and pathogenesis

Case Study

Intermittent preventive treatment for malaria among children in a refugee camp in Northern Uganda: lessons learned

Research

A deep sequencing approach to estimate Plasmodium falciparum complexity of infection (COI) and explore apical membrane antigen 1 diversity

Research

Increase in the prevalence of mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates collected from early to late pregnancy in Nanoro, Burkina Faso

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits